Results of Operations and Financial Condition
Show detailsHide details
2.02 Results of Operations and Financial Condition · 9.01 Financial Statements and Exhibits
Fate Therapeutics, Inc.
A San Diego biotech that grows "off-the-shelf" cell therapies for cancer and autoimmune disease. Using induced pluripotent stem cells — adult cells rewound to an early, flexible state — it programs batches of immune cells (natural killer and T cells) that can be stored and given to many patients, unlike therapies made from each person's own cells. Founded in 2007 by stem-cell scientists, the name comes from its mission to "direct the fate" of cells into specific immune fighters. Its ticker symbol on the stock market is fittingly FATE.
2.02 Results of Operations and Financial Condition · 9.01 Financial Statements and Exhibits
5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements · 5.07 Submission of Matters to a Vote of Security Holders · 9.01 Financial Statements and Exhibits
8.01 Other Events · 9.01 Financial Statements and Exhibits
2.02 Results of Operations and Financial Condition · 9.01 Financial Statements and Exhibits
2.02 Results of Operations and Financial Condition · 9.01 Financial Statements and Exhibits
2.02 Results of Operations and Financial Condition · 9.01 Financial Statements and Exhibits
7.01 Regulation FD Disclosure · 8.01 Other Events · 9.01 Financial Statements and Exhibits
5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements · 7.01 Regulation FD Disclosure · 9.01 Financial Statements and Exhibits